ANKTIVA is an Interleukin-15 (IL-15) receptor agonist that helps develop and activate key cells that work to destroy cancer ...

Vaccine immunotherapy targeting interleukin 6 (IL-6) has shown promising results in the treatment of inflammatory osteoarthritis of the knee, according to a phase 1 double-blind controlled study.

Tiziana Life Sciences has pointed to increased Big Pharma interest in the IL-6 pathway as justification for its decision to spin out its own candidate into a separate company. In September, Tiziana ...

BOSTON, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today ...

Introduction: Interleukin-6 (IL-6) plays an important role in the pathogenesis, progression, and severity of rheumatoid arthritis (RA). High levels of IL-6 are involved in the maintenance of ...

ACR: American College of Rheumatology; DAS: Disease activity score; DMARD: Disease-modifying antirheumatic drug; IR: Inadequate response; JSN: Joint space narrowing ...

Researchers compared the cardiovascular safety of IL-6 inhibitors vs TNF-α inhibitors among patients with rheumatoid arthritis and comorbid type 2 diabetes. Cardiovascular and renal risks were ...

Vorolanib in DURAVYU inhibits IL-6-mediated inflammation by blocking JAK receptors, showing sustained improvements in the phase 2 VERONA trial. The phase 3 program includes two non-inferiority trials, ...

Department of Respiratory and Critical Care Medicine, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, China. Interstitial lung disease, as a heterogeneous disorder characterized by ...

The last time I spoke about Tourmaline Bio, Inc. (TRML), it was with respect to a Seeking Alpha article entitled "Tourmaline Bio: TRANQUILITY Study Data Lends Credibility For IL-6 Inhibition." With ...